Speaker illustration

Miss Nadezhda Shnalieva

Almazov National Medical Research Centre, Saint Petersburg (Russian Federation)

Evaluation of preclinical atherosclerosis in chronic myeloid patients continuously treated with tyrosine kinase inhibitors

Event: ESC Congress 2019

Topic: Cardio-Oncology

Session: Cardio-oncology III

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb